SAGE Publications Uk
Primary care health consultations can be cost-effective and may help reduce cardiovascular risk
Published in Medical Letter on the CDC and FDA, September 7th, 2008
The findings are the result of a five-year randomized trial: the Ebeltoft Health Promotion Project (EHPP), conducted by the Department of General Practice, Institute of Public Health, University of Aarhus, Denmark.
More than two thousand 30-49 year olds, based in Ebeltoft,...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
More Articles from Medical Letter on the CDC and FDA
- DOE/Brookhaven National Laboratory
Addiction treatment proves successful in animal weight loss study - C. R. Bard, Inc.
JAMA Publishes Study Results on Efficacy of the Bard Agento I.C. Silver-Coated Endotracheal Tube in Preventing Ventilator-Associated Pneumonia - Clinical Trial Research
PreMD Inc. - FDA Upholds Previous NSE Decision - Dyax Corp.
Dyax Announces DX-88 for Hereditary Angioedema Meets Primary and Secondary Endpoints in Phase 3 Trial EDEMA4 - Genital Herpesvirus
BioVex Announces Regulatory Clearance to Commence a Clinical Study With ImmunoVEX HSV2; a Vaccine Candidate for Genital Herpes - HIV/AIDS
Rosetta Genomics and the National Institute of Health (NIH) to Identify Potential MicroRNA Drug Targets for HIV - More from this issue of Medical Letter on the CDC and FDA
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
